Sood Anil K, Bhatty Robert, Kamat Aparna A, Landen Charles N, Han Liz, Thaker Premal H, Li Yang, Gershenson David M, Lutgendorf Susan, Cole Steven W
Department of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, PO Box 301439, Houston, TX 77230, USA.
Clin Cancer Res. 2006 Jan 15;12(2):369-75. doi: 10.1158/1078-0432.CCR-05-1698.
There is growing evidence that stress and other behavioral factors may affect cancer progression and patient survival. The underlying mechanisms for this association are poorly understood. The purpose of this study is to determine the effects of stress-associated hormones norepinephrine, epinephrine, and cortisol on the invasive potential of ovarian cancer cells.
The ovarian cancer cells EG, SKOV3, and 222 were exposed to increasing levels of either norepinephrine, epinephrine, or cortisol, and the in vitro invasive potential was determined using the membrane invasion culture system. Additionally, the effects of these stress hormones on matrix metalloproteinase-2 (MMP-2) and MMP-9 were determined by ELISA. The effects of the beta-adrenergic agonist isoproterenol on in vivo tumor growth were determined using nude mice.
Stress levels of norepinephrine increased the in vitro invasiveness of ovarian cancer cells by 89% to 198%. Epinephrine also induced significant increases in invasion in all three cell lines ranging from 64% to 76%. Cortisol did not significantly affect invasiveness of the EG and 222 cell lines but increased invasion in the SKOV3 cell line (P = 0.01). We have previously shown that ovarian cancer cells express beta-adrenergic receptors. The beta-adrenergic antagonist propanolol (1 mumol/L) completely blocked the norepinephrine-induced increase in invasiveness. Norepinephrine also increased tumor cell expression of MMP-2 (P = 0.02 for both SKOV3 and EG cells) and MMP-9 (P = 0.01 and 0.04, respectively), and pharmacologic blockade of MMPs abrogated the effects of norepinephrine on tumor cell invasive potential. Isoproterenol treatment resulted in a significant increase in tumor volume and infiltration in the SKOV3ip1 in vivo model, which was blocked by propranolol.
These findings provide direct experimental evidence that stress hormones can enhance the invasive potential of ovarian cancer cells. These effects are most likely mediated by stimulation of MMPs.
越来越多的证据表明,压力和其他行为因素可能会影响癌症进展和患者生存。这种关联的潜在机制尚不清楚。本研究的目的是确定应激相关激素去甲肾上腺素、肾上腺素和皮质醇对卵巢癌细胞侵袭潜能的影响。
将卵巢癌细胞EG、SKOV3和222暴露于去甲肾上腺素、肾上腺素或皮质醇水平不断升高的环境中,并使用膜侵袭培养系统测定其体外侵袭潜能。此外,通过酶联免疫吸附测定法确定这些应激激素对基质金属蛋白酶-2(MMP-2)和MMP-9的影响。使用裸鼠确定β-肾上腺素能激动剂异丙肾上腺素对体内肿瘤生长的影响。
去甲肾上腺素的应激水平使卵巢癌细胞的体外侵袭性增加了89%至198%。肾上腺素也使所有三种细胞系的侵袭性显著增加,增幅在64%至76%之间。皮质醇对EG和222细胞系的侵袭性没有显著影响,但增加了SKOV3细胞系的侵袭性(P = 0.01)。我们之前已经表明卵巢癌细胞表达β-肾上腺素能受体。β-肾上腺素能拮抗剂普萘洛尔(1 μmol/L)完全阻断了去甲肾上腺素诱导的侵袭性增加。去甲肾上腺素还增加了肿瘤细胞MMP-2的表达(SKOV3和EG细胞均为P = 0.02)以及MMP-9的表达(分别为P = 0.01和0.04),并且对基质金属蛋白酶的药理阻断消除了去甲肾上腺素对肿瘤细胞侵袭潜能的影响。异丙肾上腺素治疗导致SKOV3ip1体内模型中的肿瘤体积和浸润显著增加,这被普萘洛尔阻断。
这些发现提供了直接的实验证据,表明应激激素可以增强卵巢癌细胞的侵袭潜能。这些作用很可能是由基质金属蛋白酶的刺激介导的。